Skip to content

The effect of esketamine intervention on postpartum depressive following cesarean section in chinese women: a Randomized Placebo-Controlled Study

The effect of esketamine intervention on postpartum depressive following cesarean section in chinese women: a Randomized Placebo-Controlled Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039069
Enrollment
Unknown
Registered
2020-10-15
Start date
2020-10-14
Completion date
Unknown
Last updated
2021-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Depression

Interventions

High-dose esketamine group:After delivery, participants received 0.25mg/kg intravenous esketamine (diluted to 10 mL with 0.9% saline
infusion time: 10min). The PCIA protocol was 2.2ug/kg sufentanil + 2.0mg/kg esketamine diluted to 100ml (infusion rate: 2 mL/h
infusion time: 48h)
Low-dose esketamine group:After delivery, participants received 0.25mg/kg intravenous esketamine (diluted to 10 mL with 0.9% saline
infusion time: 10min). The PCIA protocol was 2.2ug/kg sufentanil + 1.0mg/kg esketamine diluted to 100ml (infusion rate: 2 mL/h

Sponsors

The Anesthesia Department of the Third Xiangya Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years old; 2. ASA II patients; 3. Patients with gestation more than 28 weeks; 4. Patients requiring postoperative analgesia; 5. Patients with preoperative EPDS score >= 10; 6. Patients without serious cardiovascular and cerebrovascular diseases; 7. The puerpera can communicate well with the follow-up; 8. Patients who voluntarily participated in this study and signed relevant informed consent.

Exclusion criteria

Exclusion criteria: 1. Puerpera who require general anesthesia or natural labor; 2. Patients with unstable mental illness or depressive disorder; 3. Patients with severe cardiovascular and cerebrovascular diseases; 4. Patients with history of ketamine or other drugs abuse; 5. Patients who took a certain drug for a long time in the first 6 months of the study; 6. Patients with long-term drinking habit are allergic to ketamine; 7. Patients who do not have the ability to understand the language of the follow-up.

Design outcomes

Primary

MeasureTime frame
The PPD prevalence;

Secondary

MeasureTime frame
The prevalence of postpartum blues;Self-harm idea;Ramsay sedation scores;NRS score;Insomnia severity index;

Countries

China

Contacts

Public ContactDuan KM, Wang SY

The Anesthesia Department of the Third Xiangya Hospital

duankaiming@126.com+86 13974850936

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026